Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Helix BioPharma EPS Diluted (Quarterly): -0.0032 for Jan. 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -0.0032 |
| October 31, 2023 | -0.0074 |
| July 31, 2023 | -0.0075 |
| April 30, 2023 | -0.0049 |
| January 31, 2023 | -0.0074 |
| October 31, 2022 | -0.0075 |
| July 31, 2022 | 0.00 |
| April 30, 2022 | -0.0079 |
| January 31, 2022 | -0.0079 |
| October 31, 2021 | -0.008 |
| July 31, 2021 | -0.0163 |
| April 30, 2021 | -0.0159 |
| January 31, 2021 | -0.0155 |
| October 31, 2020 | -0.0302 |
| July 31, 2020 | -0.0146 |
| April 30, 2020 | -0.0146 |
| January 31, 2020 | -0.0152 |
| October 31, 2019 | -0.0151 |
| July 31, 2019 | -0.0151 |
| April 30, 2019 | -0.015 |
| January 31, 2019 | -0.015 |
| October 31, 2018 | -0.0077 |
| July 31, 2018 | -0.0153 |
| April 30, 2018 | -0.0157 |
| January 31, 2018 | -0.0237 |
| Date | Value |
|---|---|
| October 31, 2017 | -0.016 |
| July 31, 2017 | -0.0076 |
| April 30, 2017 | -0.0226 |
| January 31, 2017 | -0.0225 |
| October 31, 2016 | -0.0305 |
| July 31, 2016 | -0.0232 |
| April 30, 2016 | -0.015 |
| January 31, 2016 | -0.0219 |
| October 31, 2015 | -0.0228 |
| July 31, 2015 | -0.016 |
| April 30, 2015 | -0.024 |
| January 31, 2015 | -0.0258 |
| October 31, 2014 | -0.0271 |
| July 31, 2014 | -0.0185 |
| April 30, 2014 | -0.0271 |
| January 31, 2014 | -0.0374 |
| October 31, 2013 | -0.0289 |
| July 31, 2013 | -0.0291 |
| April 30, 2013 | -0.0295 |
| January 31, 2013 | 0.0705 |
| October 31, 2012 | -0.0304 |
| July 31, 2012 | -0.0295 |
| April 30, 2012 | -0.0402 |
| January 31, 2012 | -0.1371 |
| October 31, 2011 | -0.0499 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.0302
Minimum
Oct 2020
--
Maximum
Jul 2022
-0.0113
Average
-0.008
Median
Oct 2021
EPS Diluted (Quarterly) Benchmarks
| Acasti Pharma Inc | -0.0542 |
| Aurinia Pharmaceuticals Inc | -0.18 |
| Edesa Biotech Inc | -0.58 |
| Lexaria Bioscience Corp | -0.06 |
| Xenon Pharmaceuticals Inc | -0.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.6678M |
| Total Expenses (Quarterly) | 0.6678M |
| Enterprise Value | 31.50M |
| Earnings Yield | -16.67% |